NCT Number: NCT00544388
Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects
Controlled conditions of the EEU allow a reliable assessment of the efficacy and a determination of the action onset, action intensity and duration of effect of levocetirizine and cetirizine in order to establish the relative efficacy of these two drugs available for the treatment of SAR.
Looking for future studies?
Notify MeKey information
Conditions
Age range
16 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Male/Female, aged >= 16 years
- seasonal allergic rhinitis that required pharmacologic therapy each year during the last 2 ragweed pollen seasons
- documented seasonal allergy to ragweed pollen
- total symptom score of at least 18 points.
Exclusion criteria
- nasal anatomic deformities ? 50% obstruction
- acute sinusitis within 30 days of Period 2
- initiated or advanced an immunotherapy regimen
- immunotherapy injections within 48 hours of pollen exposure
- impaired hepatic function
- history of malignancy
- intolerance to histamines
- asthma requiring medication more than occasionally
Treatment and study plan
Primary outcomes
-
Mean change from baseline in major symptom complex score over Period 2 (21-29 hours after drug intake on Day 2).
Secondary outcomes
-
Mean change from baseline in MSC score over each 2-hour interval.
Sponsors and collaborators
Lead sponsor
UCB Pharma
Industry
Registry information
Official study title
Trial to Compare the Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects Exposed to Pollen Challenge in an Environmental Exposure Unit (EEU).
Important dates
- Study start
- 2004
- Primary completion
- 2004
- Study completion
- 2004
- First posted
- Oct 16, 2007
- Registry last updated
- Dec 16, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
An Exploratory Study of PQ Grass 27600 SU
NCT04687059
Hypersensitivity, Hypersensitivity, Immediate
Lexington, Kentucky, United States
View Trial DetailsImmunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study
NCT05960266
Hay Fever, Hypersensitivity
Zurich, Switzerland
View Trial DetailsIntralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract
NCT05297760
Allergic Asthma, Allergic Rhinitis
Zurich, Switzerland
View Trial DetailsA Dose-finding Study of ASP4070
NCT03101267
Hypersensitivity, Hypersensitivity, Immediate
Shinjuku, Tokyo, Japan
View Trial Details